Edwards Lifesciences Corp (EW)
NYSE · Healthcare · Medical Devices
Edwards Lifesciences Corp is a Healthcare company with a market capitalization of $52.27B and a trailing P/E ratio of 48.6.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $0.78 | $0.73 | +6.9% |
| Q4 2025 | February 10, 2026 | $0.58 | $0.62 | -6.4% |
| Q3 2025 | October 30, 2025 | $0.67 | $0.59 | +13.6% |
| Q2 2025 | July 24, 2025 | $0.67 | $0.62 | +8.1% |
| Q1 2025 | April 23, 2025 | $0.64 | $0.60 | +6.7% |
| Q4 2024 | February 11, 2025 | $0.59 | $0.55 | +6.4% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Edwards Lifesciences Corp's market cap?
As of June 29, 2026, Edwards Lifesciences Corp (EW) has a market capitalization of $52.27B.
What is Edwards Lifesciences Corp's P/E ratio?
Edwards Lifesciences Corp trades at a trailing price-to-earnings (P/E) ratio of 48.6. Its forward P/E is 29.9.
Does Edwards Lifesciences Corp pay a dividend?
Edwards Lifesciences Corp does not currently pay a dividend.
What sector is EW in?
Edwards Lifesciences Corp is in the Healthcare sector, specifically the Medical Devices industry.
What was Edwards Lifesciences Corp's revenue?
In its latest reported fiscal year (ending December 31, 2025), Edwards Lifesciences Corp reported revenue of $6.07B and net income of $1.07B.
Ask your own questions about EW
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.